Talacotuzumab for untreated acute myeloid leukaemia [ID1262]

  • In development
  • GID-TA10249
  • Expected publication date: TBC

Status:
In progress
Decision:
Prioritised
Process:
TA

Timeline

Key events during the development of the guidance:

Date Update
28 September 2017 In progress. In progress

For further information on our processes and methods, please see our CHTE processes and methods manual